ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Subscription

Hybridoma

Abbreviation (ISO):HYBRIDOMA
•
Identifier (ISSN):1554-0014(Print)
Clarivate JCR Index Advisory: Not Indexed in Latest JCR
Clarivate Impact Factor (IF 2024)
N/A
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓

Impact Factor Trend

Clarivate IF trend for Hybridoma

WoS Q1
000002025
Annual Impact Factor Metric
Current (2025):0
Scopus SJR & Rank
N/A

SCImago Journal Rank citation prestige weighting

Scopus / Elsevier Data
H-Index (Hirsch Index)
N/A

papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessSubscription
101articles/year
0% Gold OA•0% Original Research

Aims & Scope

Hybridoma (abbr: HYBRIDOMA, ISSN: 1554-0014) is a peer-reviewed international scholarly journal in the field of Medicine, in United States since 2005. The periodical holds tracked under Web of Science (SCIE) in quartile Q1.

Topics Covered (Recognized by AI)
Biology99.9%Medicine97.2%Genetics96.7%Immunology96.2%Antibody95%Monoclonal antibody92.3%Molecular biology85.2%Chemistry79.9%Biochemistry69.6%Gene49%Internal medicine44.2%Virology42.5%Antigen39.1%Pathology24.2%Cell biology23.3%Recombinant DNA20.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

9 year
2025Latest
IF0
Articles / Year—
Total Citations—
2012
IF—
Articles / Year101
Total Citations389
2011
IF—
Articles / Year113
Total Citations564
2010
IF—
Articles / Year119
Total Citations513
2009
IF—
Articles / Year91
Total Citations411

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
Updating
Minor Category (Specific Field):
Updating
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Hybridoma (abbr: HYBRIDOMA, ISSN: 1554-0014) is a peer-reviewed international scholarly journal in the field of Medicine, in United States since 2005. The periodical holds tracked under Web of Science (SCIE) in quartile Q1.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 101 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with APC fees are not specified. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Subscription
Publisher
Updating
Publication Language
English
Frequency
Bimonthly
Founding Year
2005
Indexing & Databases
PubMed
Editorial Address
MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 81b895e3-fff4-4c4e-a342-a365b164b9b5
Database Updated: 2026-10-01